Medical News Today: Herceptin for HER2-positive breast cancer improves long-term survival

A new study shows that when added to chemotherapy, trastuzumab – commonly known as Herceptin – significantly improves long-term survival of HER2-positive breast cancer patients.

 

 

healthnews.juicyworldnews.com/uncategorized/medical-news-...

 

chemotherapy, Herceptin, patients, study, survival

Done